April 2nd 2025
Charles River Laboratories will work directly with the platform.
A look at the current landscape and how young companies can set the stage for product launch.
FDA Approves Expanded Label of Novartis’ Prostate Cancer Treatment, Pluvicto
Based on additional results from the Phase III PSMAfore clinical trial, the therapy is now approved for use prior to chemotherapy in PSMA-positive metastatic castration-resistant prostate cancer.
Critical Shortcomings in the US' Public Health Crisis Plans
March 28th 2025Marcel Botha, CEO of 10XBeta, discusses shortcomings in the US's emergency plans for rapid innovation and manufacturing during public health crises, highlighting the need for innovation pipelines, supply chain resilience, and regulatory clarity.